1
|
Banerjee A, Athalye S, Khargekar N, Shingade P, Madkaikar M. Chronic Hepatitis B and Related Liver Diseases Are Associated with Reduced 25-Hydroxy-Vitamin D Levels: A Systematic Review and Meta-Analysis. Biomedicines 2023; 11:biomedicines11010135. [PMID: 36672644 PMCID: PMC9855868 DOI: 10.3390/biomedicines11010135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2022] [Revised: 12/19/2022] [Accepted: 12/31/2022] [Indexed: 01/06/2023] Open
Abstract
Hepatitis B infection is a major public health problem globally leading to chronic liver disease and death, which are influenced by various environmental and host factors including serum 25-hydroxy-vitamin D levels. There is no comprehensive systematic review reporting the association of serum 25-hydroxy-vitamin D levels and different stages of chronic hepatitis B. This study aimed to analyze the association of 25-hydroxy-vitamin D levels in chronic hepatitis B with various determinants and outcomes. A bibliographic search in PubMed, Google Scholar, and Scopus was conducted using the search terms “Vitamin D”, “cholecalciferol”, “calcitriol”, “Hepatitis B”, and “HBV”, which were published until September 2022. Meta-analysis using the “metafor” package in R was conducted with a random effect model. This analysis included 33 studies with 6360 chronic hepatitis B patients. The pooled estimates of serum 25-hydroxy-vitamin D level among CHB cases was 21.05 ng/mL and was significantly lower compared to healthy controls. (p < 0.005). Reduced serum 25-hydroxy-vitamin D level was significantly associated with the severity of liver fibrosis as well as HBe positivity. This analysis suggests that serum 25-hydroxy-vitamin D levels are associated with disease activity and pathobiology, although the exact nature of the cause−effect relationship cannot be discerned from this study.
Collapse
Affiliation(s)
- Anindita Banerjee
- Transfusion Transmitted Disease Department, ICMR-National Institute of Immunohaematology, Parel, Mumbai 400012, India
- Correspondence: ; Tel.: +91-22-2413-8518/19
| | - Shreyasi Athalye
- Transfusion Transmitted Disease Department, ICMR-National Institute of Immunohaematology, Parel, Mumbai 400012, India
| | - Naveen Khargekar
- Hematogenetics Department, ICMR-National Institute of Immunohaematology, Parel, Mumbai 400012, India
| | - Poonam Shingade
- Department of Community Medicine, ESIC Medical College, Gulbarga 585106, India
| | - Manisha Madkaikar
- Pediatric Immunology & Leukocyte Biology Department, ICMR-National Institute of Immunohaematology, Parel, Mumbai 400012, India
| |
Collapse
|
2
|
Ravaioli F, Pivetti A, Di Marco L, Chrysanthi C, Frassanito G, Pambianco M, Sicuro C, Gualandi N, Guasconi T, Pecchini M, Colecchia A. Role of Vitamin D in Liver Disease and Complications of Advanced Chronic Liver Disease. Int J Mol Sci 2022; 23:ijms23169016. [PMID: 36012285 PMCID: PMC9409132 DOI: 10.3390/ijms23169016] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2022] [Revised: 08/09/2022] [Accepted: 08/11/2022] [Indexed: 12/12/2022] Open
Abstract
Vitamin D is a crucial nutrient with many pleiotropic effects on health and various chronic diseases. The purpose of this review is to provide a detailed report on the pathophysiological mechanisms underlying vitamin D deficiency in patients with chronic liver disease, addressing the different liver etiologies and the condition of advanced chronic liver disease (cirrhosis) with related complications. To date, patients with liver disease, regardless of underlying etiology, have been shown to have reduced levels of vitamin D. There is also evidence of the predictive role of vitamin D values in complications and progression of advanced disease. However, specific indications of vitamin D supplementation are not conclusive concerning what is already recommended in the general population. Future studies should make an effort to unify and validate the role of vitamin D supplementation in chronic liver disease.
Collapse
Affiliation(s)
- Federico Ravaioli
- Gastroenterology Unit, Department of Medical Specialties, University Hospital of Modena, University of Modena & Reggio Emilia, 41121 Modena, Italy
- Department of Medical and Surgical Sciences, University of Bologna, 40128 Bologna, Italy
- Correspondence:
| | - Alessandra Pivetti
- Gastroenterology Unit, Department of Medical Specialties, University Hospital of Modena, University of Modena & Reggio Emilia, 41121 Modena, Italy
| | - Lorenza Di Marco
- Gastroenterology Unit, Department of Medical Specialties, University Hospital of Modena, University of Modena & Reggio Emilia, 41121 Modena, Italy
- Clinical and Experimental Medicine PhD Program, University of Modena & Reggio Emilia, 41121 Modena, Italy
| | - Christou Chrysanthi
- Gastroenterology Unit, Department of Medical Specialties, University Hospital of Modena, University of Modena & Reggio Emilia, 41121 Modena, Italy
| | - Gabriella Frassanito
- Gastroenterology Unit, Department of Medical Specialties, University Hospital of Modena, University of Modena & Reggio Emilia, 41121 Modena, Italy
| | - Martina Pambianco
- Gastroenterology Unit, Department of Medical Specialties, University Hospital of Modena, University of Modena & Reggio Emilia, 41121 Modena, Italy
| | - Chiara Sicuro
- Gastroenterology Unit, Department of Medical Specialties, University Hospital of Modena, University of Modena & Reggio Emilia, 41121 Modena, Italy
| | - Noemi Gualandi
- Gastroenterology Unit, Department of Medical Specialties, University Hospital of Modena, University of Modena & Reggio Emilia, 41121 Modena, Italy
| | - Tomas Guasconi
- Gastroenterology Unit, Department of Medical Specialties, University Hospital of Modena, University of Modena & Reggio Emilia, 41121 Modena, Italy
| | - Maddalena Pecchini
- Gastroenterology Unit, Department of Medical Specialties, University Hospital of Modena, University of Modena & Reggio Emilia, 41121 Modena, Italy
| | - Antonio Colecchia
- Gastroenterology Unit, Department of Medical Specialties, University Hospital of Modena, University of Modena & Reggio Emilia, 41121 Modena, Italy
| |
Collapse
|
3
|
Lee PC, Hsieh YC, Huo TI, Yang UC, Lin CH, Li CP, Huang YH, Hou MC, Lin HC, Lee KC. Active Vitamin D 3 Treatment Attenuated Bacterial Translocation via Improving Intestinal Barriers in Cirrhotic Rats. Mol Nutr Food Res 2021; 65:e2000937. [PMID: 33258263 DOI: 10.1002/mnfr.202000937] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2020] [Revised: 11/23/2020] [Indexed: 12/19/2022]
Abstract
SCOPE Pathological bacterial translocation from the disrupted intestinal barrier leads to substantial complications and mortality in liver cirrhosis. Vitamin D is reported as beneficial to gut barriers in some animal models. However, its effect on cirrhotic bacterial translocation is unknown. The authors aim to investigate the effects of calcitriol on bacterial translocation in cirrhotic rats. METHODS AND RESULTS Cirrhotic rats are administrated with a 2-week course of active vitamin D3 (calcitriol, 0.1 μg kg-1 per day) or vehicle by oral gavage after thioacetamide (TAA) injection for 16 weeks. Bacterial translocation, gut permeability, gut microbiota, and associated mechanisms are investigated. Calcitriol treatment significantly attenuates bacterial translocation and reduces intestinal permeability in TAA-induced cirrhotic rats. It upregulates the expressions of occludin in the small intestine and claudin-1 in the colon of cirrhotic rats directly independent of intrahepatic status. Even when a short period of calcitriol treatment do not reduce intestinal bacterial overgrowth, it induces a remarkable change of bacterial diversities and enrichment of Muribaculaceae, Bacteroidales, Allobaculum, Anaerovorax, and Ruminococcaceae. CONCLUSION Calcitriol treatment attenuates intestinal permeability, reduces bacterial translocation, and enriches potentially beneficial gut microbiota in cirrhotic rats that may enable it as a potential therapeutic agent to prevent cirrhotic complications.
Collapse
Affiliation(s)
- Pei-Chang Lee
- Institute of Pharmacology, National Yang Ming University, 155, Sec. 2, Li-Nong Street, Taipei, 11217, Taiwan
- Faculty of Medicine, National Yang Ming University, Taipei 11221, Taiwan., 155, Sec. 2, Li-Nong Street, Taipei, 11221, Taiwan
- Division of Gastroenterology and Hepatology, Department of Medicine, 201 Shih-Pai Road, Sec. 2, Taipei, 11217, Taiwan
| | - Yun-Chen Hsieh
- Institute of Pharmacology, National Yang Ming University, 155, Sec. 2, Li-Nong Street, Taipei, 11217, Taiwan
- Faculty of Medicine, National Yang Ming University, Taipei 11221, Taiwan., 155, Sec. 2, Li-Nong Street, Taipei, 11221, Taiwan
- Division of Gastroenterology and Hepatology, Department of Medicine, 201 Shih-Pai Road, Sec. 2, Taipei, 11217, Taiwan
| | - Teh-Ia Huo
- Institute of Pharmacology, National Yang Ming University, 155, Sec. 2, Li-Nong Street, Taipei, 11217, Taiwan
- Faculty of Medicine, National Yang Ming University, Taipei 11221, Taiwan., 155, Sec. 2, Li-Nong Street, Taipei, 11221, Taiwan
- Division of Basic Research, Department of Medical Research, Taipei Veterans General Hospital, 201 Shih-Pai Road, Sec. 2, Taipei, 11217, Taiwan
| | - Ueng-Cheng Yang
- Institute of Biomedical Informatics, National Yang Ming University, 155, Sec. 2, Li-Nong Street, Taipei, 11221, Taiwan
| | - Chao-Hsiung Lin
- Department of Life Sciences and Institute of Genome Sciences, National Yang Ming University, 155, Sec. 2, Li-Nong Street, Taipei, 11221, Taiwan
- Proteomics Research Center, National Yang Ming University, 155, Sec. 2, Li-Nong Street, Taipei, 11221, Taiwan
| | - Chung-Pin Li
- Faculty of Medicine, National Yang Ming University, Taipei 11221, Taiwan., 155, Sec. 2, Li-Nong Street, Taipei, 11221, Taiwan
- Division of Gastroenterology and Hepatology, Department of Medicine, 201 Shih-Pai Road, Sec. 2, Taipei, 11217, Taiwan
| | - Yi-Hsiang Huang
- Faculty of Medicine, National Yang Ming University, Taipei 11221, Taiwan., 155, Sec. 2, Li-Nong Street, Taipei, 11221, Taiwan
- Division of Gastroenterology and Hepatology, Department of Medicine, 201 Shih-Pai Road, Sec. 2, Taipei, 11217, Taiwan
- Institute of Clinical Medicine, National Yang Ming University, 155, Sec. 2, Li-Nong Street, Taipei, 11221, Taiwan
| | - Ming-Chih Hou
- Faculty of Medicine, National Yang Ming University, Taipei 11221, Taiwan., 155, Sec. 2, Li-Nong Street, Taipei, 11221, Taiwan
- Division of Gastroenterology and Hepatology, Department of Medicine, 201 Shih-Pai Road, Sec. 2, Taipei, 11217, Taiwan
| | - Han-Chieh Lin
- Faculty of Medicine, National Yang Ming University, Taipei 11221, Taiwan., 155, Sec. 2, Li-Nong Street, Taipei, 11221, Taiwan
- Division of Gastroenterology and Hepatology, Department of Medicine, 201 Shih-Pai Road, Sec. 2, Taipei, 11217, Taiwan
| | - Kuei-Chuan Lee
- Faculty of Medicine, National Yang Ming University, Taipei 11221, Taiwan., 155, Sec. 2, Li-Nong Street, Taipei, 11221, Taiwan
- Division of Gastroenterology and Hepatology, Department of Medicine, 201 Shih-Pai Road, Sec. 2, Taipei, 11217, Taiwan
| |
Collapse
|